feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Cantargia: USA-patent för CAN03
Research Note
2018-05-21
08:56
Cantargia har stärkt patentsituationen i USA för bolagets autoimmuna/inflammatoriska program CANxx.
MS
Mathias Spinnars
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans